• Home
  • Docetaxel, estramustine, plus trastuzumab in patients with metastatic androgen-independent prostate cancer.

Docetaxel, estramustine, plus trastuzumab in patients with metastatic androgen-independent prostate cancer.

Author List
Small EJ, Bok R, Reese DM, Sudilovsky D, Frohlich M
Publication
Seminars in oncology
Publication ID (Profile URL)
https://researcherprofiles.org/profile/1425469
Publication Year
2001
PubMed ID
11685733
Publication Title
Small EJ, Bok R, Reese DM, Sudilovsky D, Frohlich M. Docetaxel, estramustine, plus trastuzumab in patients with metastatic androgen-independent prostate cancer. Semin Oncol. 2001 Aug; 28(4 Suppl 15):71-6.